BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales: Lyu, Yinfeng, Li, Kunping, Li, Yuqing, Wen, Hui, Feng, Chenchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933017/
https://www.ncbi.nlm.nih.gov/pubmed/33784008
http://dx.doi.org/10.1002/ctm2.348
_version_ 1783660534233563136
author Lyu, Yinfeng
Li, Kunping
Li, Yuqing
Wen, Hui
Feng, Chenchen
author_facet Lyu, Yinfeng
Li, Kunping
Li, Yuqing
Wen, Hui
Feng, Chenchen
author_sort Lyu, Yinfeng
collection PubMed
description
format Online
Article
Text
id pubmed-7933017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79330172021-03-15 BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors Lyu, Yinfeng Li, Kunping Li, Yuqing Wen, Hui Feng, Chenchen Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-03-04 /pmc/articles/PMC7933017/ /pubmed/33784008 http://dx.doi.org/10.1002/ctm2.348 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Lyu, Yinfeng
Li, Kunping
Li, Yuqing
Wen, Hui
Feng, Chenchen
BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title_full BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title_fullStr BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title_full_unstemmed BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title_short BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
title_sort bcl2l2 loss renders ‐14q renal cancer dependent on bcl2l1 that mediates resistance to tyrosine kinase inhibitors
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933017/
https://www.ncbi.nlm.nih.gov/pubmed/33784008
http://dx.doi.org/10.1002/ctm2.348
work_keys_str_mv AT lyuyinfeng bcl2l2lossrenders14qrenalcancerdependentonbcl2l1thatmediatesresistancetotyrosinekinaseinhibitors
AT likunping bcl2l2lossrenders14qrenalcancerdependentonbcl2l1thatmediatesresistancetotyrosinekinaseinhibitors
AT liyuqing bcl2l2lossrenders14qrenalcancerdependentonbcl2l1thatmediatesresistancetotyrosinekinaseinhibitors
AT wenhui bcl2l2lossrenders14qrenalcancerdependentonbcl2l1thatmediatesresistancetotyrosinekinaseinhibitors
AT fengchenchen bcl2l2lossrenders14qrenalcancerdependentonbcl2l1thatmediatesresistancetotyrosinekinaseinhibitors

Ejemplares similares